HK1089448A1 - Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases - Google Patents

Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases

Info

Publication number
HK1089448A1
HK1089448A1 HK06110000A HK06110000A HK1089448A1 HK 1089448 A1 HK1089448 A1 HK 1089448A1 HK 06110000 A HK06110000 A HK 06110000A HK 06110000 A HK06110000 A HK 06110000A HK 1089448 A1 HK1089448 A1 HK 1089448A1
Authority
HK
Hong Kong
Prior art keywords
nucleosidases
nucleoside phosphorylases
preparing inhibitors
inhibitors
preparing
Prior art date
Application number
HK06110000A
Other languages
English (en)
Inventor
Evans Gary Brian
Tyler Peter Charles
Original Assignee
Ind Res Ltd
Einstein Coll Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Res Ltd, Einstein Coll Med filed Critical Ind Res Ltd
Publication of HK1089448A1 publication Critical patent/HK1089448A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK06110000A 2003-02-04 2006-09-08 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases HK1089448A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ523970A NZ523970A (en) 2003-02-04 2003-02-04 Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
PCT/NZ2004/000017 WO2004069856A1 (en) 2003-02-04 2004-01-30 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases

Publications (1)

Publication Number Publication Date
HK1089448A1 true HK1089448A1 (en) 2006-12-01

Family

ID=32844996

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06110000A HK1089448A1 (en) 2003-02-04 2006-09-08 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases

Country Status (16)

Country Link
US (2) US7655795B2 (pt)
EP (1) EP1590360B1 (pt)
JP (1) JP4806746B2 (pt)
KR (1) KR101185120B1 (pt)
CN (1) CN100357308C (pt)
BR (1) BRPI0407210A (pt)
CA (1) CA2514992C (pt)
CY (1) CY1113297T1 (pt)
DK (1) DK1590360T3 (pt)
ES (1) ES2391043T3 (pt)
HK (1) HK1089448A1 (pt)
NZ (1) NZ523970A (pt)
PT (1) PT1590360E (pt)
RU (1) RU2334757C2 (pt)
SI (1) SI1590360T1 (pt)
WO (1) WO2004069856A1 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985848A (en) * 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
CN1196704C (zh) * 1999-04-08 2005-04-13 工业研究有限公司 制备核苷代谢抑制剂的方法及中间体化合物
RU2330042C2 (ru) 2002-08-21 2008-07-27 Альберт Эйнштейн Колледж Оф Медсин Оф Йешива Юниверсити Ингибиторы нуклеозидфосфорилаз и нуклеозидаз
NZ523970A (en) * 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
NZ533360A (en) * 2004-06-04 2007-02-23 Ind Res Ltd Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
NZ540160A (en) * 2005-05-20 2008-03-28 Einstein Coll Med Inhibitors of nucleoside phosphorylases
EP1924684A4 (en) * 2005-07-27 2009-02-11 Einstein Coll Med STRUCTURE OF TRANSITION STATUS OF 5'-METHYLTHIOADENOSINE / S-ADENOSYLHOMOCYSTEINE NUCLEOSIDASES
NZ544187A (en) * 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
WO2007097643A1 (en) * 2006-02-22 2007-08-30 Industrial Research Limited Analogues of coformycin and their use for treating protozoan parasite infections
US8916571B2 (en) * 2006-02-24 2014-12-23 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase
AU2007218334A1 (en) * 2006-02-24 2007-08-30 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases
CN101094080B (zh) * 2006-06-22 2012-06-20 华为技术有限公司 一种即按即通系统中的计费方法
AU2007293774C1 (en) 2006-09-07 2014-12-18 Albert Einstein College Of Medicine, Inc. Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
US8383636B2 (en) * 2006-09-07 2013-02-26 Industrial Research Limited Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
CN101600711A (zh) * 2006-12-22 2009-12-09 工业研究有限公司 核苷酶和磷酸化酶抑制剂的氮杂环丁烷类似物
US20110190265A1 (en) * 2008-09-22 2011-08-04 Schramm Vern L Methods and compositions for treating bacterial infections by inhibiting quorum sensing
ES2519568T3 (es) * 2009-03-24 2014-11-07 Biocryst Pharmaceuticals, Inc. Sales farmacéuticas útiles de 7-[(3R,4R)-3-hidroxi-4-hidroximetil-pirrolidin-1-ilmetil]-3,5-dihidro-pirrolo[3,2-d]pirimidin-4-ona
CA2768291C (en) 2009-07-17 2018-03-27 Albert Einstein College Of Medicine Of Yeshiva University 3-hydroxypyrrolidine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
CA2794671C (en) 2010-03-31 2018-05-01 Gilead Pharmasset Llc Stereoselective synthesis of phosphorus containing actives
WO2012074912A1 (en) 2010-11-29 2012-06-07 Albert Einstein College Of Medicine Of Yeshiva University Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
US11186575B2 (en) * 2012-08-07 2021-11-30 Alber Einslein College of Medicine Treatment of helicobacter pylori infections
CN111499639B (zh) * 2019-01-31 2022-03-04 四川大学华西医院 嘧啶酮衍生物及其在制药中的应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60433B1 (en) * 1986-08-26 1994-07-13 Warner Lambert Co Novel 9-deazaguanines
US5101030A (en) * 1986-08-26 1992-03-31 Warner-Lambert Company 9-deazaguanines
US4988702A (en) * 1986-08-26 1991-01-29 Warner-Lambert Company Novel 9-deazaguanines
US5061707A (en) * 1986-08-26 1991-10-29 Warner-Lambert Company 9-deazaguanines to treat psoriasis
US5102879A (en) * 1986-08-26 1992-04-07 Warner-Lambert Company Method of treating gout with novel 9-deazaguanines
US4923872A (en) * 1986-08-26 1990-05-08 Warner-Lambert Co. Analogues of pyrrolo[3,2d]pyrimidin-4-ones
US5008270A (en) * 1989-10-31 1991-04-16 Biocryst, Inc. 2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US4985434A (en) * 1989-10-31 1991-01-15 Biocryst, Inc. 7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
AU654264B2 (en) * 1989-10-31 1994-11-03 Biocryst Pharmaceuticals, Inc. Inhibitors of purine nucleoside phosphorylase
US4985433A (en) * 1989-10-31 1991-01-15 Biocryst, Inc. 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US5008265A (en) * 1989-10-31 1991-04-16 Biocryst, Inc. 2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US5726311A (en) * 1989-11-29 1998-03-10 Biocryst Pharmaceuticals, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo 3,2-d!pyrimidine and pharmaceutical uses and compositions containing the same
US5189039A (en) * 1989-11-29 1993-02-23 Biocryst, Inc. 7-disubstituted-methyl-4-oxo-3H,5H-pyrrolo[3,2d]pyrimidine and pharmaceutical uses and compositions containing the same
US6379911B2 (en) 1996-02-23 2002-04-30 Albert Einstein College Of Medicine Of Yeshiva University Enzyme detection/assay method and substrates
WO1998013045A1 (fr) * 1996-09-24 1998-04-02 Taiho Pharmaceutical Co., Ltd. Inhibiteurs de metastases cancereuses contenant des derives d'uracile
US5985848A (en) 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
CN1196704C (zh) 1999-04-08 2005-04-13 工业研究有限公司 制备核苷代谢抑制剂的方法及中间体化合物
WO2002018371A1 (en) 2000-08-29 2002-03-07 Industrial Research Limited Nucleoside metabolism inhibitors
US6458799B1 (en) 2000-08-31 2002-10-01 Biocryst Pharmaceuticals, Inc. Deazaguanine analog, preparation thereof and use thereof
US7098334B2 (en) 2002-03-25 2006-08-29 Industrial Research Limited 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
RU2330042C2 (ru) * 2002-08-21 2008-07-27 Альберт Эйнштейн Колледж Оф Медсин Оф Йешива Юниверсити Ингибиторы нуклеозидфосфорилаз и нуклеозидаз
NZ523970A (en) * 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
NZ533360A (en) * 2004-06-04 2007-02-23 Ind Res Ltd Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
AU2005269541A1 (en) 2004-07-27 2006-02-09 Biocryst Pharmaceuticals, Inc. Inhibitors of 5'-methylthioadenosine phosphorylase and 5'methylthioadenosine/s-adenosylhomocysteine nucleosidase
NZ540160A (en) 2005-05-20 2008-03-28 Einstein Coll Med Inhibitors of nucleoside phosphorylases
NZ544187A (en) 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
AU2007218334A1 (en) 2006-02-24 2007-08-30 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating diseases using inhibitors of nucleoside phosphorylases and nucleosidases
US8916571B2 (en) * 2006-02-24 2014-12-23 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating cancer using inhibitors of 5′-methylthioadenosine phosphorylase
US8383636B2 (en) * 2006-09-07 2013-02-26 Industrial Research Limited Acyclic amine inhibitors of 5-methytioadenosine phosphorylase and nucleosidase
WO2008039324A1 (en) * 2006-09-26 2008-04-03 Albert Einstein College Of Medicine Of Yeshiva University Transition state structure of human 5'-methylthioadenosine phosphorylase
CN101600711A (zh) * 2006-12-22 2009-12-09 工业研究有限公司 核苷酶和磷酸化酶抑制剂的氮杂环丁烷类似物

Also Published As

Publication number Publication date
EP1590360A4 (en) 2009-06-24
RU2005127630A (ru) 2006-06-27
WO2004069856A1 (en) 2004-08-19
EP1590360B1 (en) 2012-07-11
KR20050114614A (ko) 2005-12-06
US7655795B2 (en) 2010-02-02
JP4806746B2 (ja) 2011-11-02
EP1590360A1 (en) 2005-11-02
ES2391043T3 (es) 2012-11-20
CN100357308C (zh) 2007-12-26
US20060217551A1 (en) 2006-09-28
SI1590360T1 (sl) 2012-11-30
BRPI0407210A (pt) 2006-01-24
AU2004208968A1 (en) 2004-08-19
CA2514992C (en) 2012-08-07
PT1590360E (pt) 2012-08-27
CA2514992A1 (en) 2004-08-19
DK1590360T3 (da) 2012-08-27
CY1113297T1 (el) 2016-04-13
RU2334757C2 (ru) 2008-09-27
CN1771254A (zh) 2006-05-10
NZ523970A (en) 2005-02-25
KR101185120B1 (ko) 2012-09-21
US20100094003A1 (en) 2010-04-15
JP2006516615A (ja) 2006-07-06

Similar Documents

Publication Publication Date Title
HK1089448A1 (en) Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
EP1490373A4 (en) INHIBITORS OF NUCLEOSIDE PHOSPHORYLASES AND NUCLEOSIDASES
PT1562589E (pt) Diaminotriazoles úteis como inibidores de proteína-quinases
HK1072545A1 (en) Novel inhibitors of kinases
EP1601357A4 (en) HETEROCYCLIC KINASE INHIBITORS: METHOD OF USE AND SYNTHESIS
HK1077057A1 (en) Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
ZA200704888B (en) Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
AU2003251559A8 (en) Heterocyclic inhibitors of kinases
HK1099764A1 (en) Quinoxalines useful as inhibitors of protein kinases
AU2003238822A1 (en) Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
AU2003221801A8 (en) Compositions selective for adenosine diphosphate and methods of using same
EP1991231A4 (en) METHOD FOR THE TREATMENT OF DISEASES WITH NUCLEOSIDE PHOSPHORUSLASES AND NUCLEOSIDASES INHIBITORS
EP1805119A4 (en) POLYCRYSTALLINE ALUMINA ARTICLES AND METHODS OF MAKING
IL175657A0 (en) Derivatives of dihydronepetalactone and method for preparation
SI1618111T1 (sl) Soli klopidogrela in postopek za pripravo
AU2003260945A8 (en) Methods of use for thermostable rna ligases
HK1090377A1 (en) Process for the preparation of tubulin inhibitors
AU2003210983A8 (en) Kinase inhibitors and methods of use thereof
EP1547993A4 (en) PROCESS FOR PREPARING SPIROFLUORENOLS
AU2003256006A8 (en) Improved process for preparation of risperidone
ZA200500414B (en) Process for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinases
HUP0500513A3 (en) Intermediates for preparing glycogen phosphorylase inhibitors
ZA200500492B (en) Novel inhibitors of kinases
SI1509525T1 (sl) Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
PL361149A1 (en) Method for manufacture of modified nucleotides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140130